Locally advanced breast cancer is the number of dissected nodes after neoadjuvant chemotherapy important?

ecancermedicalscience 2026 Open access

Read full text
Authors: Josepmilly del Valle Peña Colmenares, Wladimir José Villegas Rodríguez, Osama Bahsas-Zaky, Carlos Martínez, Douglas José Angulo Herrera
DOI: 10.3332/ecancer.2026.2070
Cited by: 0

Abstract

Objective: To assess whether the number of lymph nodes (LN) in breast cancer (BC) patients undergoing axillary dissection (AD) after neoadjuvant chemotherapy affects disease-free survival (DFS) and overall survival (OS). Methods: Descriptive, retrospective, longitudinal cut-off study (2011-2020).Results: 391 patients, 176 patients in the

Fields of Study & Subjects

Breast Cancer Treatment Studies Breast Lesions and Carcinomas MRI in cancer diagnosis

Publication details

Journal / source
ecancermedicalscience
Volume
20
Pages
2070–2070
Publication date
30 January 2026
Language
EN